4.3  -0.14 (-3.15%)		05-19 15:59
Open: 4.57 High: 4.63 Volume: 35,704		Pre. Close: 4.44 Low: 4.25 Market Cap: 27(M)

Short term
Mid term
Targets	6-month :	4.67	1-year :	5.19
Resists	First :	4	Second :	4.44
Pivot price	4.04
Supports	First :	3.27	Second :	2.72
MAs	MA(5) :	3.98	MA(20) :	4.06
	MA(100) :	5.21	MA(250) :	5.18
MACD	MACD :	-0.2	Signal :	-0.2
%K %D	K(14,3) :	41.4	D(3) :	45.6
RSI	RSI(14): 42.1
52-week	High :	11.98	Low :	2.59

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ ANPC ] has closed above bottom band by 4.3%. Bollinger Bands are 77.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 41 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	4.1 - 4.13	4.13 - 4.15
Low:	3.74 - 3.77	3.77 - 3.79
Close:	3.76 - 3.8	3.8 - 3.84

AnPac Bio-Medical Science Co., Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup package services. The company was incorporated in 2010 and is headquartered in Lishui, the People's Republic of China.

Tue, 09 May 2023
Sidoti's Micro-Cap Virtual May Conference - Yahoo Finance

Thu, 20 Oct 2022
Good Penny Stocks To Buy Now? 7 Under $1 To Watch This Week - PennyStocks.com

Fri, 05 Aug 2022
AnPac Bio Announces Appointment of New Directors and Co-Chief Executive Officer - GlobeNewswire

Mon, 30 Aug 2021
AnPac Bio’s USA Laboratory Receives Accreditation from the College of American Pathologists - GlobeNewswire

Tue, 06 Oct 2020
The Daily Biotech Pulse: Pfizer, BioNTech Begin European Filing For Coronavirus Vaccine, Y-mAbs BLA Rejected, GlycoMimetics Granted Rare Pediatric Disease Designation - Yahoo Finance

Fri, 19 Jun 2020
2020 IPO Next-Gen Cancer Screening AnPac Sees Growth in US and China - 24/7 Wall St.

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Outperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	6 (M)
Shares Float	6 (M)
Held by Insiders	2.1 (%)
Held by Institutions	0.1 (%)
Shares Short	44 (K)
Shares Short P.Month	28 (K)

EPS	-11.45
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	10.63
Profit Margin	0 %
Operating Margin	-871.2 %
Return on Assets (ttm)	-52.7 %
Return on Equity (ttm)	-243.2 %
Qtrly Rev. Growth	-70 %
Gross Profit (p.s.)	0
Sales Per Share	1.7
EBITDA (p.s.)	-14.04
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	-0.34
PEG Ratio	0
Price to Book value	0.35
Price to Sales	2.23
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.